HR 9696: Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act
HR 9696 in plain English: This bill aims to reduce diagnostic errors in medicine by authorizing federal funding for programs to improve how diseases and conditions are identified. It authorizes a total of three separate funding streams for efforts spanning fiscal years 2027 through 2031.
Stated purpose
The bill aims to improve the quality, accuracy, and timeliness of medical diagnosis in the United States by funding research, building centers of excellence, and developing tools to reduce diagnostic errors and the health care waste they cause.
Key points
- Authorizes $45,000,000 per year for fiscal years 2027 through 2031 for a diagnostic improvement program
- Authorizes $20,000,000 per year for fiscal years 2027 through 2030 for a related program
- Authorizes $1,500,000 per year for fiscal years 2027 through 2030 for an additional program
- Aims to reduce health care waste and save lives by addressing errors in medical diagnosis
Arguments supporters make
- Diagnostic errors are a leading cause of preventable patient harm, so investing in research and best practices could save lives and reduce suffering.
- Reducing misdiagnoses and diagnostic delays could cut wasteful health care spending by avoiding unnecessary treatments and repeated testing.
- Including patients, families, and AI-driven tools in the research process ensures solutions will be practical and reflect what matters most to those affected.
Arguments opponents make
- Authorizing $45 million per year creates a significant new federal spending commitment with no guarantee the research will translate into measurable improvements at the bedside.
- The bill adds new mandates and bureaucratic structures to an existing agency, which critics may argue duplicates efforts already underway rather than filling a genuine gap.
- Relying on federal research programs to fix diagnosis problems may overlook that solutions often depend on local clinical culture and individual provider training, areas the government is poorly positioned to change.
Tradeoffs
Funding a large, multi-year federal research program could generate valuable tools and save lives, but it requires sustained public spending with outcomes that may be difficult to measure or may take years to materialize. Centralizing diagnostic quality improvement through a federal agency may accelerate broad adoption of best practices but could reduce flexibility for health systems to tailor solutions to their own patients and contexts.
Current status in Congress: In committee.
NewsClear — neutral news & congressional tracking · Bill of the Week